Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma
Modern Pathology Aug 09, 2017
Quesada AE, et al. – This trial involved the study of the prognostic significance of extra copies of MYC, BCL2, or BCL6, in patients with diffuse large B–cell lymphoma. It was observed that intensive induction chemotherapy regimens improved the overall survival of patients with double or triple extra copy lymphoma. However, no significant improvement was noted of the overall survival in patients with MYC–R tumors. MYC extra copy in diffuse large B–cell lymphoma served as an independent poor prognostic factor, similar to MYC rearrangement.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries